source
- Merck to test experimental sac-TMT antibody-drug conjugate with Keytruda in lung cancer trialMerck announced it will start a clinical trial testing its experimental antibody-drug conjugate sac-TMT together with the immunotherapy Keytruda in patients with lung cancer. The study will assess…
- Eli Lilly expands early-access program for experimental obesity drug retatrutideEli Lilly announced it will broaden its early-access initiative for retatrutide, an investigational drug targeting obesity. The company said the program will let additional patients apply for the…